Patent directory · USPTO A61K / A61P
Patents matching “NIKANG THERAPEUTICS, INC.”
13 pharma patents match "NIKANG THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 13 pharmaceutical patents matching "NIKANG THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12415779
Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof
granted -
US 12391642
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12331026
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors
granted -
US 12264167
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
granted -
US 12171741
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12077506
Indane derivatives as hypoxia inducible factor-2(α) inhibitors
granted -
US 11753366
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 11518772
Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
granted -
US 11459340
Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors
granted -
US 11420936
Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases
granted -
US 11267782
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors
granted -
US 11034705
Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
granted -
US 10894797
Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors
granted